0.6567
price up icon4.24%   0.0267
after-market Handel nachbörslich: .61 -0.0467 -7.11%
loading
Schlusskurs vom Vortag:
$0.63
Offen:
$0.617
24-Stunden-Volumen:
146.03K
Relative Volume:
0.12
Marktkapitalisierung:
$5.28M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.26M
KGV:
-0.0122
EPS:
-53.609
Netto-Cashflow:
$-12.17M
1W Leistung:
-4.23%
1M Leistung:
-17.71%
6M Leistung:
-16.66%
1J Leistung:
-98.24%
1-Tages-Spanne:
Value
$0.582
$0.70
1-Wochen-Bereich:
Value
$0.582
$0.70
52-Wochen-Spanne:
Value
$0.3015
$63.57

Gri Bio Inc Stock (GRI) Company Profile

Name
Firmenname
Gri Bio Inc
Name
Telefon
(619) 400-1171
Name
Adresse
2223 AVENIDA DE LA PLAYA, LA JOLLA
Name
Mitarbeiter
4
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
GRI's Discussions on Twitter

Vergleichen Sie GRI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GRI
Gri Bio Inc
0.6567 5.28M 0 -8.26M -12.17M -53.61
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
438.40 113.67B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
683.08 74.97B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
665.68 40.50B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
277.16 35.95B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
120.88 29.63B 3.30B -501.07M 1.03B -2.1146

Gri Bio Inc Stock (GRI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-09 Eingeleitet H.C. Wainwright Buy

Gri Bio Inc Aktie (GRI) Neueste Nachrichten

pulisher
Jan 28, 2025

Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust - GlobeNewswire

Jan 28, 2025
pulisher
Jan 20, 2025

IN8bio Inc (NASDAQ: INAB): What’s Next After The Stock Plunge? - Stocks Register

Jan 20, 2025
pulisher
Jan 20, 2025

Windtree Therapeutics Appoints Leanne Kelly to Board of Directors and Audit Committee - Defense World

Jan 20, 2025
pulisher
Jan 17, 2025

Windtree Therapeutics Appoints Leanne Kelly to Board, Advances New Growth Strategy - MyChesCo

Jan 17, 2025
pulisher
Jan 13, 2025

Windtree Announces the Addition of Leanne Kelly to Its Board of Directors - The Manila Times

Jan 13, 2025
pulisher
Jan 13, 2025

Windtree Therapeutics Strengthens Board with Biotech Finance Veteran Leanne Kelly - StockTitan

Jan 13, 2025
pulisher
Jan 12, 2025

Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews

Jan 12, 2025
pulisher
Jan 11, 2025

Pre-market Movers: HSDT, PBM, MTEM, APTO... - RTTNews

Jan 11, 2025
pulisher
Jan 09, 2025

The GRI Marketing Group Joins SDL to Accelerate North America CX Growth Strategy - Yahoo Finance

Jan 09, 2025
pulisher
Dec 29, 2024

Short Interest in GRI Bio, Inc. (NASDAQ:GRI) Increases By 155.5% - Defense World

Dec 29, 2024
pulisher
Dec 29, 2024

FLYHT Aerospace Solutions Ltd. (OTCMKTS:FLYLF) Sees Significant Growth in Short Interest - Defense World

Dec 29, 2024
pulisher
Dec 27, 2024

Viracta stock falls on strategic review (VIRX:NASDAQ) - Seeking Alpha

Dec 27, 2024
pulisher
Dec 23, 2024

GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and - EIN News

Dec 23, 2024
pulisher
Dec 23, 2024

GRI Bio Announces European Patent Office Issued a Decision - GlobeNewswire

Dec 23, 2024
pulisher
Dec 23, 2024

GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and Its Library of 500+ Proprietary Compounds - GlobeNewswire Inc.

Dec 23, 2024
pulisher
Dec 19, 2024

Mainz Biomed stock higher on Quest deal (MYNZ:NASDAQ) - Seeking Alpha

Dec 19, 2024
pulisher
Dec 10, 2024

GRI Bio (NASDAQ:GRI) Now Covered by HC Wainwright - Defense World

Dec 10, 2024
pulisher
Dec 09, 2024

GRI Bio Inc (NASDAQ: GRI): What’s Next After The Stock Plunge? - Stocks Register

Dec 09, 2024
pulisher
Dec 09, 2024

Astera Labs Inc: Is ALAB Stock Worth Buying? - Stocks Register

Dec 09, 2024
pulisher
Dec 09, 2024

Pre-market Movers: SXTC, STIM, BIOA, UPC... - RTTNews

Dec 09, 2024
pulisher
Dec 06, 2024

GRI Bio to Participate in the Virtual Investor Closing Bell Series - GlobeNewswire

Dec 06, 2024
pulisher
Dec 06, 2024

GRI Bio to Present Corporate Strategy at Virtual Investor Closing Bell Series - StockTitan

Dec 06, 2024
pulisher
Nov 21, 2024

GRI Bio reports progress in IPF treatment with GRI-0621 - Investing.com India

Nov 21, 2024
pulisher
Nov 21, 2024

GRI Bio Showcases GRI-0621’s Potential to Reduce - GlobeNewswire

Nov 21, 2024
pulisher
Nov 21, 2024

GRI Bio's IPF Drug Shows Promise in Preclinical Data, Phase 2a Trial Underway | GRI Stock News - StockTitan

Nov 21, 2024
pulisher
Nov 20, 2024

GRI Bio files to sell 1.58M shares of common stock for holders - MSN

Nov 20, 2024
pulisher
Nov 15, 2024

SEC Form 424B3 filed by GRI Bio Inc. - Quantisnow

Nov 15, 2024
pulisher
Nov 15, 2024

GRI Bio Inc (GRI) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 14, 2024

GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

GRI Bio Raises $13.9M, Extends Runway for Key IPF Drug Trial Data in 2025 | GRI Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 08, 2024

GRI Bio Inc expected to post a loss of 73 cents a shareEarnings Preview - XM

Nov 08, 2024
pulisher
Nov 04, 2024

Ascendiant Capital Initiates Coverage of GRI Bio (GRI) with Buy Recommendation - MSN

Nov 04, 2024
pulisher
Nov 04, 2024

Beam Therapeutics (BEAM) Stock Surges with Strong Trading Volume - GuruFocus.com

Nov 04, 2024
pulisher
Nov 01, 2024

Curis (CRIS) Stock Plummets Over 5% Amid Lack of Institutional R - GuruFocus.com

Nov 01, 2024
pulisher
Oct 31, 2024

Capricor Therapeutics (CAPR) Faces 5% Drop Amid Industry Slump - GuruFocus.com

Oct 31, 2024
pulisher
Oct 28, 2024

Primary Sclerosing Cholangitis Pipeline 2024: Clinical Trials - openPR

Oct 28, 2024
pulisher
Oct 25, 2024

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80% - MSN

Oct 25, 2024
pulisher
Oct 25, 2024

GRI Bio secures funding to advance IPF treatment into 2025 - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

GRI Bio secures funding to advance IPF treatment into 2025 By Investing.com - Investing.com UK

Oct 24, 2024
pulisher
Oct 24, 2024

GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024 - GlobeNewswire

Oct 24, 2024
pulisher
Oct 23, 2024

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Oct 23, 2024
pulisher
Oct 22, 2024

Dow Falls Over 150 Points; General Motors Tops Q3 Views - Benzinga

Oct 22, 2024
pulisher
Oct 22, 2024

Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 22, 2024
pulisher
Oct 21, 2024

U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.80% - MSN

Oct 21, 2024
pulisher
Oct 21, 2024

GRI Bio Announces Exercise of Warrants - GlobeNewswire

Oct 21, 2024
pulisher
Oct 21, 2024

Dyne Therapeutics (DYN) Shares Plummet Amid Market Volatility - GuruFocus.com

Oct 21, 2024
pulisher
Oct 21, 2024

Top Innovation Stocks Surge: PRSO, SYTA, SAVE, ISPC, GRI, BIVIMust-Watch Stocks This Week - openPR

Oct 21, 2024
pulisher
Oct 21, 2024

Energy storage ‘key’ to sustainability – report - Yahoo! Voices

Oct 21, 2024
pulisher
Oct 21, 2024

As iPhone Sales Soar in China, Is It Time to Buy Apple Stock? - Yahoo! Voices

Oct 21, 2024
pulisher
Oct 21, 2024

2 Artificial Intelligence (AI) Stocks That Are No-Brainer Buys - Yahoo! Voices

Oct 21, 2024
pulisher
Oct 21, 2024

Statkraft seeks approval for 2.1GW offshore wind farm in Baltic Sea - Yahoo! Voices

Oct 21, 2024

Finanzdaten der Gri Bio Inc-Aktie (GRI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Kapitalisierung:     |  Volumen (24h):